Metformin Use Linked to Lower Risk for Joint Replacement in T2DM
MONDAY, Dec. 19, 2022 -- For patients with type 2 diabetes, metformin use is associated with a reduced risk for total knee replacement (TKR) and total hip replacement (THR), according to a study published online Dec. 19 in CMAJ, the journal of the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Metformin | Orthopaedics | Pharmaceuticals | Study